George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension
01 juil. 2021 02h00 HE
|
George Medicines
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...
George Medicines appoints Stefan König as Chief Executive Officer
03 juin 2021 07h00 HE
|
George Medicines
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...
George Medicines appoints Stefan König as Chief Executive Officer
03 juin 2021 02h00 HE
|
George Medicines
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...